Dengue Bulletin

Yellow-fever Vaccinating Centres
The designation of yellow-fever vaccinating
centres is the responsibility of national health
administrations according to the
requirements of the International Health
Regulations, Article 66, paragraph 4, which
states: “The yellow-fever vaccine used must
be approved by the Organization, and the
vaccinating centre must have been
designated by the health administration for
the territory in which it is situated…”.
In recent years the number of centres
designated has increased considerably in
many countries and it is no longer possible
to maintain an up-to-date list of all centres
which would be available continuously to all
health administrations. For this reason, it was
decided in 1997 to cease publication of the
names of these centres. It is therefore no
longer necessary for health administrations
to inform WHO of the designation of new
yellow-fever vaccinating centres. Anyone
wishing to obtain information on such
centres should address questions directly to
the national health administration of the
country concerned.
The list of approved yellow-fever
vaccine producers is published annually in
International Travel and Health.
Weekly Epidemiological Record 2002, 77(8): 61
For easy reference the list as of 1
January 2002 is as follows:
Aventis Pasteur
58, avenue Leclerc
BP 7046
69348 Lyon Cedex 07
France
BioManguinhos
Av Brasil 4365 – Manguinhos
21045-900 rio de Janeiro/RJ
Brazil
Institut Pasteur Dakar
BP 220
36, avenue Pasteur
Dakar
Senegal
Celltech Group plc (formerly Medeva, U.K.)
Evans House, Regent Park
Kingston Road
Leatherhead LT22 7PQ
United Kingdom
Any updates are given at the following
web address:
http://www.who.int/vaccines-access/ vaccines/
Vaccine_Quality/ UN_Pre-qualified/unyf
producers.html.
Dengue Bulletin – Vol 26, 2002 217